Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Preliminary studies suggest that glucagon-like peptide-1 receptor (GLP-1) agonists, used to treat type 2 diabetes and obesity ...

(HealthDay News) — For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

NRBO READ THE FULL NRBO RESEARCH REPORT Business Update Topline Results from Phase 2a Trial of DA-1241 in MASH Expected in ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight, according to a study ...

The numbers are based on users or healthcare workers informing the regulator of adverse reactions to the drugs, known as ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

Similar to Lilly's weight loss treatments (Mounjaro and Zepbound), VK2735 is a dual glucagon-like peptide 1 (GLP-1) and ...

Garner, MD, Medical Director at SimpleFixRx to review it all for accuracy. Dr, Garner said, "Glucagon-like peptide-1 (GLP-1) ...